Beller G A
Cardiovascular Division, University of Virginia, Charlottesville 22908, USA.
Q J Nucl Med. 1996 Mar;40(1):55-67.
Identifying preserved myocardial viability in the presence of severe regional left ventricular dysfunction is becoming increasingly more important for clinical decision-making to better select those patients with coronary artery disease who will benefit most from revascularization. 201Tl remains the most commonly employed radionuclide for detecting both ischemia and viability. A post-exercise defect showing complete or partial redistribution on delayed images implies transient ischemia and preserved viability with a 90% chance of exhibiting improved 201Tl uptake with repeat testing after coronary revascularization. Mild persistent defects with < 50% 201Tl uptake on 4-hour redistribution images also imply viability with a 60-70% probability of showing improved 201Tl uptake after repeat imaging following revascularization with concomitant enhancement of regional systolic function. In contrast, a severe persistent defect with < 50% 201Tl uptake compared to peak uptake has only a 15% chance of exhibiting improved perfusion and corresponding improved function after revascularization. Detection of defect reversibility on 201Tl imaging is enhanced by "reinjection" of a second 201Tl dose after acquisition of redistribution images. Initial and 4-hour rest/redistribution imaging has proven most useful for detection of viability in the resting state in patients with ischemic cardiomyopathy. The greater the extent of preoperative viability, the greater is the improvement in regional and global function after revascularization. 99mTc sestamibi has also been demonstrated to be extracted by myocardial cells in proportion to regional blood flow in the presence of viable myocites. Although this agent does not redistribute after intravenous injection, its > 50% uptake of the tracer implies viability and predicts improved regional function after revascularization. Finally, positron emission tomography with 18F fluorodeoxyglucose (FDG) is perhaps the most sensitive noninvasive imaging technique for detection of viability in stunned or hibernating myocardium. A mismatch pattern between regional flow and FDG uptake has approximately an 80-85% positive predicted value for predicting improved function in asynergic myocardial regions after revascularization. A match pattern where flow and FDG uptake are both reduced has an 80% negative predicted value for lack of functional recovery after revascularization.
在严重的左心室局部功能障碍情况下识别保留的心肌活力,对于临床决策变得越来越重要,以便更好地选择那些将从血运重建中获益最大的冠心病患者。铊-201(201Tl)仍然是检测缺血和活力最常用的放射性核素。运动后缺损在延迟图像上显示完全或部分再分布意味着短暂性缺血和保留的活力,冠状动脉血运重建后重复检测时,有90%的机会显示铊-201摄取改善。4小时再分布图像上铊-201摄取<50%的轻度持续性缺损也意味着有活力,血运重建并伴随局部收缩功能增强后重复成像时,有60 - 70%的概率显示铊-201摄取改善。相比之下,与峰值摄取相比铊-201摄取<50%的严重持续性缺损,血运重建后灌注改善及相应功能改善的机会仅为15%。在获取再分布图像后“再次注射”第二剂铊-201可增强铊-201成像上缺损可逆性的检测。初始和4小时静息/再分布成像已被证明对检测缺血性心肌病患者静息状态下的活力最有用。术前活力范围越大,血运重建后局部和整体功能的改善就越大。锝-99m(99mTc)甲氧基异丁基异腈(sestamibi)也已被证明在有存活心肌细胞存在时,心肌细胞会按局部血流比例摄取。尽管该药物静脉注射后不会再分布,但其示踪剂摄取>50%意味着有活力,并预测血运重建后局部功能改善。最后,18F氟脱氧葡萄糖(FDG)正电子发射断层扫描可能是检测顿抑或冬眠心肌活力最敏感的非侵入性成像技术。局部血流与FDG摄取之间的不匹配模式对于预测血运重建后协同失调心肌区域功能改善的阳性预测值约为80 - 85%。血流和FDG摄取均降低的匹配模式对于血运重建后缺乏功能恢复的阴性预测值为80%。